Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes

Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes

US Patent 8697628 · Granted Apr 15, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for adversarial annotations2025
Case2025
Methods for fructokinase mediation of alcohol craving and alcohol induced liver 2024
Methods for fructokinase mediation of alcohol craving and alcohol induced liver 2024
Apparatus for and method cleaning a support inside a lithography apparatus2022
Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-med2021
Selective inhibition of V1b for treating fatty liver2021
Targeting AMP deaminase 2 for ameliorating craving for sugar and other substance2021
Rapid exchange device for lithography reticles2018
Use of ERBB3 inhibitors in the treatment of triple negative and basal-like breas2016
Methods and compositions for the inhibition of fructokinase2016
Methods and compositions for the inhibition of fructokinase2016